- Home
- CGEN vs ATLO Comparison
CGEN vs ATLO Comparison
Compare CGEN & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- ATLO
- Stock Information
- Founded
- CGEN 1993
- ATLO 1903
- Country
- CGEN Israel
- ATLO United States
- Employees
- CGEN N/A
- ATLO N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- ATLO Major Banks
- Sector
- CGEN Health Care
- ATLO Finance
- Exchange
- CGEN Nasdaq
- ATLO Nasdaq
- Market Cap
- CGEN 142.4M
- ATLO 144.8M
- IPO Year
- CGEN 2000
- ATLO N/A
- Fundamental
- Price
- CGEN $2.25
- ATLO $17.42
- Analyst Decision
- CGEN Strong Buy
- ATLO
- Analyst Count
- CGEN 1
- ATLO 0
- Target Price
- CGEN $4.00
- ATLO N/A
- AVG Volume (30 Days)
- CGEN 898.9K
- ATLO 29.6K
- Earning Date
- CGEN 03-04-2025
- ATLO 01-28-2025
- Dividend Yield
- CGEN N/A
- ATLO 5.80%
- EPS Growth
- CGEN N/A
- ATLO N/A
- EPS
- CGEN 0.02
- ATLO 0.98
- Revenue
- CGEN $59,852,000.00
- ATLO $51,071,000.00
- Revenue This Year
- CGEN $57.27
- ATLO N/A
- Revenue Next Year
- CGEN N/A
- ATLO N/A
- P/E Ratio
- CGEN $125.59
- ATLO $17.71
- Revenue Growth
- CGEN 698.03
- ATLO N/A
- 52 Week Low
- CGEN $1.35
- ATLO $15.69
- 52 Week High
- CGEN $3.03
- ATLO $22.41
- Technical
- Relative Strength Index (RSI)
- CGEN 81.70
- ATLO 58.97
- Support Level
- CGEN $1.92
- ATLO $16.04
- Resistance Level
- CGEN $2.16
- ATLO $17.93
- Average True Range (ATR)
- CGEN 0.15
- ATLO 0.44
- MACD
- CGEN 0.07
- ATLO 0.16
- Stochastic Oscillator
- CGEN 88.90
- ATLO 73.02
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.